Bio-Techne Corporation (TECH)
After hours:
- Simply Wall St.
Calculating The Fair Value Of Bio-Techne Corporation (NASDAQ:TECH)
Key Insights Bio-Techne's estimated fair value is US$68.96 based on 2 Stage Free Cash Flow to Equity Current share...
- PR Newswire
BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS
Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, October 30, 2024, at 8:00 a.m. CDT to review its first quarter fiscal 2025 financial results.
- PR Newswire
ScaleReady announces a G-Rex® Grant has been awarded to LIfT Biosciences
ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, and LIfT BioSciences, ('LIfT' or 'the Company'), a rapidly emerging biotech company about to start clinical trials for its first-in-class allogeneic innate cell therapy, today announced that LIfT Biosciences has been awarded a $300,000 G-Rex® Grant to establish clinical manufacturing of its promising Neutrophil only Leukocyte Infusion Therapy (N-LIfT) platform.
